Insider trading

Period: 120 months Stock: VYGR Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

68 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

68 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

68 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

68 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
68 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
68 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

68 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
24 Feb 2026
Swartz Robin COO & CBO
Sold on a plan
$24.35K 6,458 at 3.77
3.1%
Planned (10b5-1)
24 Feb 2026
Carter Todd Alfred Chief Scientific Officer
Sold on a plan
$15.69K 4,174 at 3.76
2.8%
Planned (10b5-1)
18 Feb 2026
Swartz Robin COO & CBO
Sold on a plan
$13.35K 3,882 at 3.44
1.8%
Planned (10b5-1)
18 Feb 2026
Carter Todd Alfred Chief Scientific Officer
Sold on a plan
$11.36K 3,301 at 3.44
2.2%
Planned (10b5-1)
10 Feb 2026
Swartz Robin COO & CBO
Sold at will
$17.59K 4,569 at 3.85
2.1%
Not planned
10 Feb 2026
Carter Todd Alfred Chief Scientific Officer
Sold at will
$13.57K 3,525 at 3.85
2.2%
Not planned
18 Aug 2025
Ferguson Toby Chief Medical Officer
Sold at will
$70.87K 19,000 at 3.73
12.0%
Not planned
2 Apr 2025
Ferguson Toby Chief Medical Officer
Sold at will
$34.59K 10,086 at 3.43
6.0%
Not planned
20 Feb 2025
Swartz Robin COO & CBO
Sold at will
$16.55K 3,894 at 4.25
3.8%
Not planned
20 Feb 2025
Carter Todd Alfred Chief Scientific Officer
Sold at will
$14.08K 3,305 at 4.26
4.1%
Not planned
11 Feb 2025
Swartz Robin COO & CBO
Sold at will
$30.93K 6,950 at 4.45
6.4%
Not planned
11 Feb 2025
Carter Todd Alfred Chief Scientific Officer
Sold at will
$24.09K 5,413 at 4.45
6.3%
Not planned
11 Feb 2025
Fahey Sandell Jacquelyn Chief Legal Officer
Sold at will
$19.39K 4,358 at 4.45
5.1%
Not planned
14 Jan 2025
Swartz Robin COO & CBO
Sold at will
$15.71K 3,087 at 5.09
2.7%
Not planned
14 Jan 2025
Carter Todd Alfred Chief Scientific Officer
Sold at will
$6.11K 1,191 at 5.13
1.4%
Not planned
23 Dec 2024
Swartz Robin COO&CBO
Sold at will
$36.73K 6,500 at 5.65
5.5%
Not planned
2 Oct 2024
Fahey Sandell Jacquelyn Chief Legal Officer
Sold at will
$34.91K 5,999 at 5.82
6.5%
Not planned
2 Apr 2024
Swartz Robin Chief Operating Officer
Sold at will
$13.41K 1,357 at 9.88
1.1%
Not planned
21 Feb 2024
Swartz Robin Chief Operating Officer
Sold at will
$29.55K 3,966 at 7.45
3.2%
Not planned
21 Feb 2024
Carter Todd Alfred Chief Scientific Officer
Sold at will
$25.14K 3,365 at 7.47
3.7%
Not planned
20 Feb 2024
Carter Todd Alfred Chief Scientific Officer
Sold at will
$4.62K 602 at 7.68
0.7%
Not planned
17 Jan 2024
Swartz Robin Chief Operating Officer
Sold at will
$18.18K 2,543 at 7.15
3.4%
Not planned
17 Jan 2024
Carter Todd Alfred Chief Scientific Officer
Sold at will
$9.09K 1,266 at 7.18
2.3%
Not planned
15 Sep 2023
Carter Todd Alfred Chief Scientific Officer
Sold on a plan
$85.68K 10,500 at 8.16
16.2%
Planned (10b5-1)
6 Jul 2023
Carter Todd Alfred Chief Scientific Officer
Sold on a plan
$59.40K 5,500 at 10.80
8.4%
Planned (10b5-1)
30 Jun 2023
Carter Todd Alfred Chief Scientific Officer
Sold on a plan
$57.05K 5,000 at 11.41
7.1%
Planned (10b5-1)
3 Apr 2023
Swartz Robin Chief Operating Officer
Sold at will
$9.86K 1,259 at 7.83
1.7%
Not planned
20 Mar 2023
Hesslein Robert W. Senior VP & General Counsel
Sold at will
$34.22K 4,410 at 7.76
4.1%
Not planned
20 Mar 2023
Swartz Robin Chief Operating Officer
Sold at will
$28.36K 3,654 at 7.76
4.8%
Not planned
20 Mar 2023
Carter Todd Alfred Chief Scientific Officer
Sold at will
$17.02K 2,193 at 7.76
3.2%
Not planned
15 Mar 2023
Swartz Robin Chief Operating Officer
Sold, plan not stated
$126.06K 15,373 at 8.20
16.7%
17 Feb 2023
Hesslein Robert W. Senior VP & General Counsel
Sold, plan not stated
$24.56K 3,297 at 7.45
3.0%
17 Feb 2023
Carter Todd Alfred Chief Scientific Officer
Sold, plan not stated
$5.50K 738 at 7.45
1.1%
13 Feb 2023
Hesslein Robert W. Senior VP & General Counsel
Sold, plan not stated
$22.00K 2,868 at 7.67
2.5%
13 Feb 2023
Carter Todd Alfred Chief Scientific Officer
Sold, plan not stated
$6.11K 797 at 7.67
2.3%
17 Jan 2023
Swartz Robin Chief Operating Officer
Sold, plan not stated 2×
$21.55K 2,188 at 9.85
4.0%
17 Jan 2023
Hesslein Robert W. Senior VP & General Counsel
Sold, plan not stated 2×
$21.55K 2,188 at 9.85
1.9%
17 Jan 2023
Carter Todd Alfred Chief Scientific Officer
Sold, plan not stated 2×
$10.89K 1,106 at 9.85
3.1%
6 Jan 2023
Carter Todd Alfred Chief Scientific Officer
Sold, plan not stated
$2.49K 388 at 6.41
1.1%
4 Apr 2022
Hesslein Robert W. Senior VP & General Counsel
Sold, plan not stated
$22.98K 2,786 at 8.25
2.4%
4 Apr 2022
Swartz Robin Chief Operating Officer
Sold, plan not stated
$12.60K 1,527 at 8.25
2.8%
21 Mar 2022
Hesslein Robert W. Senior VP & General Counsel
Sold, plan not stated 2×
$41.10K 4,955 at 8.29
4.0%
21 Mar 2022
Swartz Robin Chief Operating Officer
Sold, plan not stated 2×
$36.60K 4,413 at 8.29
7.6%
21 Mar 2022
Burek Julie VP, Finance
Sold, plan not stated 2×
$21.97K 2,649 at 8.29
4.8%
17 Feb 2022
Hesslein Robert W. Senior VP & General Counsel
Sold, plan not stated
$14.56K 4,100 at 3.55
3.2%
17 Feb 2022
Burek Julie VP, Finance
Sold, plan not stated
$2.80K 789 at 3.55
1.4%
11 Feb 2022
Hesslein Robert W. Senior VP & General Counsel
Sold, plan not stated
$10.93K 3,252 at 3.36
2.5%
11 Feb 2022
Burek Julie VP, Finance
Sold, plan not stated
$1.21K 361 at 3.36
0.6%
12 Jan 2022
Burek Julie VP, Finance
Sold, plan not stated
$810.90 265 at 3.06
0.6%
3 Jan 2022
Burek Julie VP, Finance
Sold, plan not stated
$8.67K 3,063 at 2.83
6.2%
Showing 1–50 of 68. Page 1 of 2 Older →